AZD 7295

Drug Profile

AZD 7295

Alternative Names: A-689; AZD-7295

Latest Information Update: 12 Nov 2016

Price : $50

At a glance

  • Originator Arrow Therapeutics
  • Class Antivirals
  • Mechanism of Action Hepatitis C virus NS 5 protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Hepatitis C

Most Recent Events

  • 27 Jan 2011 Discontinued - Phase-I for Hepatitis C in Japan (PO)
  • 27 Jan 2011 Discontinued - Phase-I for Hepatitis C in New Zealand (PO)
  • 27 Jan 2011 Discontinued - Phase-II for Hepatitis C in United Kingdom (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top